Increased Cdk5/p35 activity in the dentate gyrus mediates depressive-like behaviour in rats

International Journal of Neuropsychopharmacology

Volumn 15, Issue 6, 2012, Pages 795-809

  Zhu, Wei Li ^a   Shi, Hai Shui ^a   Wang, Shen Jun ^a   Xu, Chun Mei ^a   Jiang, Wen Gao ^a   Wang, Xi ^a   Wu, Ping ^a   Li, Qian Qian ^a   Ding, Zeng Bo ^a   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Butyrolactone; Cdk5; chronic mild stress; depression; p35

Indexed keywords

ARIPIPRAZOLE; CYCLIN DEPENDENT KINASE 5; MIRTAZAPINE; PROTEIN P35; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR; CHRONIC MILD STRESS; CONTROLLED STUDY; CYTOSOL; DENTATE GYRUS; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MENTAL STRESS; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT;

4-BUTYROLACTONE; ANIMALS; ANTIDEPRESSIVE AGENTS; COLD TEMPERATURE; DENTATE GYRUS; DEPRESSION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EXPLORATORY BEHAVIOR; FOOD PREFERENCES; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAVENTRICULAR; MALE; PHOSPHOTRANSFERASES; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; SUCROSE; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 84862125015     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000915     Document Type: Article

References (63)

1. Ayala R, Shu T, Tsai LH (2007). Trekking across the brain : the journey of neuronal migration. Cell 128, 29-43. (Pubitemid 46055273)
2. Bajaj NP, al-Sarraj ST, Leigh PN, Anderson V, et al. (1999). Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Progress in Neuro-Psychopharmacology and Biological Psychiatry 23, 833-850. (Pubitemid 29416758)
3. Bignante EA, Rodriguez Manzanares PA, Mlewski EC, Bertotto ME, et al. (2008). Involvement of septal Cdk5 in the emergence of excessive anxiety induced by stress. European Neuropsychopharmacology 18, 578-588.
4. Brion JP, Couck AM (1995). Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. American Journal of Pathology 147, 1465-1476.
5. Campbell S, Marriott M, Nahmias C, MacQueenGM(2004). Lower hippocampal volume in patients suffering from depression: a meta-analysis. American Journal of Psychiatry 161, 598-607. (Pubitemid 38445502)
6. Chen AC, Shirayama Y, Shin KH, Neve RL, et al. (2001a). Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biological Psychiatry 49, 753-762. (Pubitemid 32452296)
7. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, et al. (2001b). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50, 260-265. (Pubitemid 32778442)
8. Chen J, Zhang Y, Kelz MB, Steffen C, et al. (2000). Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures : role of [Delta]FosB. Journal of Neuroscience 20, 8965-8971. (Pubitemid 32042896)
9. Chen PC, Chen JC (2005). Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats. Neuropsychopharmacology 30, 538-549.
10. Conrad CD (2008). Chronic stress-induced hippocampal vulnerability : the glucocorticoid vulnerability hypothesis. Reviews in the Neurosciences 19, 395-411.
11. Cruz JC, Tseng HC, Goldman JA, Shih H, et al. (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483. (Pubitemid 37494698)
12. Duman R, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Archives of General Psychiatry 54, 597-606. (Pubitemid 27306570)
13. Duman RS (2004). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Medicine 5, 11-25. (Pubitemid 38391953)
14. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127.
15. Fischer A, Sananbenesi F, Pang PT, Lu B, et al. (2005). Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48, 825-838. (Pubitemid 41759432)
16. Fischer A, Sananbenesi F, Schrick C, Spiess J, et al. (2002). Cyclin-dependent kinase 5 is required for associative learning. Journal of Neuroscience 22, 3700-3707. (Pubitemid 37465775)
17. Gee CE, Benquet P, Raineteau O, Rietschin L, et al. (2006). NMDA receptors and the differential ischemic vulnerability of hippocampal neurons. European Journal of Neuroscience 23, 2595-2603. (Pubitemid 43801451)
18. Gong X, Tang X, Wiedmann M, Wang X, et al. (2003). Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38, 33-46. (Pubitemid 36423351)
19. Greengard P (2001). The neurobiology of slow synaptic transmission. Science 294, 1024-1030. (Pubitemid 33041850)
20. Hershberger PA, LaCount DJ, Friesen PD (1994). The apoptotic suppressor P35 is required early during baculovirus replication and is targeted to the cytosol of infected cells. Journal of Virology 68, 3467-3477.
21. Kitagawa M, Higashi H, Takahashi IS, Okabe T, et al. (1994). A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. Oncogene 9, 2549-2557. (Pubitemid 24254030)
22. Kitagawa M, Okabe T, Ogino H, Matsumoto H, et al. (1993). Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Oncogene 8, 2425-2432. (Pubitemid 23252371)
23. Lee M, Kwon YT, Li M, Peng J, et al. (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364. (Pubitemid 30337070)
24. Lew J, Huang QQ, Qi Z, Winkfein RJ, et al. (1994). A brain-specific activator of cyclin-dependent kinase 5. Nature 371, 423-426. (Pubitemid 24302557)
25. Li BS, Zhang L, Takahashi S, Ma W, et al. (2002). Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO Journal 21, 324-333. (Pubitemid 34137294)
26. Li FQ, Xue YX, Wang JS, Fang Q, et al. (2010). Basolateral amygdala cdk5 activity mediates consolidation and reconsolidation of memories for cocaine cues. Journal of Neuroscience 30, 10351-10359.
27. Li YQ, Li FQ, Wang XY, Wu P, et al. (2008). Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. Journal of Neuroscience 28, 13248-13257.
28. Lin YH, Liu AH, Xu Y, Tie L, et al. (2005). Effect of chronic unpredictable mild stress on brain-pancreas relative protein in rat brain and pancreas. Behavioural Brain Research 165, 63-71. (Pubitemid 41476205)
29. Liu F, Ma XH, Ule J, Bibb JA, et al. (2001). Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proceedings of the National Academy of Sciences USA 98, 11062-11068. (Pubitemid 32928683)
30. Liu WK, Williams RT, Hall FL, Dickson DW, et al. (1995). Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. American Journal of Pathology 146, 228-238.
31. Lu L, Hope BT, Dempsey J, Liu SY, et al. (2005). Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nature Neuroscience 8, 212-219. (Pubitemid 40194052)
32. Luo DD, An SC, Zhang X (2008). Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress. Brain Research Bulletin 77, 8-12.
33. McEwen BS (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience 22, 105-122. (Pubitemid 29144882)
34. Murray CJ, Lopez AD (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349, 1498-1504. (Pubitemid 27216360)
35. Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, et al. (1998). Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy. Journal of Neuropathology and Experimental Neurology 57, 690-698. (Pubitemid 28335058)
36. Nakamura S, Kawamoto Y, Nakano S, Ikemoto A, et al. (1997). Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis. Neurology 48, 267-270. (Pubitemid 27039555)
37. Nguyen MD, Lariviere RC, Julien JP (2001). Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30, 135-147. (Pubitemid 32441682)
38. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15, 7539-7547.
39. Ohshima T, Ward JM, Huh CG, Longenecker G, et al. (1996). Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proceedings of the National Academy of Sciences USA 93, 11173-11178. (Pubitemid 26333137)
40. Papp M, Willner P, Muscat R (1991). An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berlin) 104, 255-259.
41. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, et al. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622. (Pubitemid 129516324)
42. Paxinos G, Watson CR, Emson PC (1980). AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. Journal of Neuroscience Methods 3, 129-149. (Pubitemid 11162950)
43. Roy M, Hom J, Sapolsky RM (2001). Neuroprotection with herpes simplex vectors expressing virally derived antiapoptotic agents. Brain Research 901, 12-22. (Pubitemid 32718800)
44. Roy M, Hom JJ, Sapolsky RM (2002). HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption. Gene Therapy 9, 214-219. (Pubitemid 34189582)
45. Roy M, Sapolsky RM (2003). The neuroprotective effects of virally-derived caspase inhibitors p35 and crmA following a necrotic insult. Neurobiology of Disease 14, 1-9. (Pubitemid 37103174)
46. Sananbenesi F, Fischer A, Wang X, Schrick C, et al. (2007). A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nature Neuroscience 10, 1012-1019. (Pubitemid 47185210)
47. Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 18, 391-418. (Pubitemid 47356367)
48. Shirayama Y, Chen AC, Nakagawa S, Russell DS, et al. (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22, 3251-3261. (Pubitemid 35379212)
49. Smith DS, Tsai LH (2002). Cdk5 behind the wheel: a role in trafficking and transport? Trends in Cell Biology 12, 28-36. (Pubitemid 34164154)
50. Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, et al. (2002). Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proceedings of the National Academy of Sciences USA 99, 3182-3187. (Pubitemid 34240606)
51. Takahashi M, Iseki E, Kosaka K (2000). Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary tangles-bearing neurons in Alzheimer type dementia brains. Journal of Neuroscience 172, 63-69. (Pubitemid 30006983)
52. Tan TC, Valova VA, Malladi CS, Graham ME, et al. (2003). Cdk5 is essential for synaptic vesicle endocytosis. Nature Cell Biology 5, 701-710. (Pubitemid 36986777)
53. Tsai LH, Delalle I, Caviness VS, Chae T, et al. (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419-423. (Pubitemid 24302556)
54. Ubeda M, Rukstalis JM, Habener JF (2006). Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. Journal of Biological Chemistry 281, 28858-28864. (Pubitemid 44507029)
55. Van Riel E, Meijer OC, Steenbergen PJ, Joels M (2003). Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons. Neuroscience 120, 649-658. (Pubitemid 36928063)
56. Videbech P, Ravnkilde B (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry 161, 1957-1966. (Pubitemid 39441394)
57. Wallace DL, Han MH, Graham DL, Green TA, et al. (2009). CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nature Neuroscience 12, 200-209.
58. Wang D, An SC, Zhang X (2008). Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neuroscience Letters 433, 59-64.
59. Wang Q, Yu S, Simonyi A, Sun GY, et al. (2005). Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Molecular Neurobiology 31, 3-16. (Pubitemid 41271190)
60. Wang X, Luo YX, He YY, Li FQ, et al. (2010). Nucleus accumbens core mammalian target of rapamycin signaling pathway is critical for cue-induced reinstatement of cocaine seeking in rats. Journal of Neuroscience 30, 12632-12641.
61. Warner-Schmidt JL, Duman RS (2006). Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16, 239-249.
62. Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin) 134, 319-329. (Pubitemid 28023396)
63. Willner P, Towell A, Sampson D, Sophokleous S, et al. (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berlin) 93, 358-364. (Pubitemid 17160661)